Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
Nat Immunol
    March 2024
  1. FUMAGALLI V, Rava M, Marotta D, Di Lucia P, et al
    Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.
    Nat Immunol. 2024 Mar 14. doi: 10.1038/s41590-024-01787.
    >> Share

  2. TRAN KA, Pernet E, Sadeghi M, Downey J, et al
    BCG immunization induces CX3CR1(hi) effector memory T cells to provide cross-protection via IFN-gamma-mediated trained immunity.
    Nat Immunol. 2024;25:418-431.
    >> Share

    February 2024

  3. A mechanism for BCG vaccine cross-protection against pulmonary viral infections.
    Nat Immunol. 2024 Feb 21. doi: 10.1038/s41590-024-01775.
    >> Share


  4. A nasal vaccine elicits protective CD8(+) T cell immunity against antigen shifted SARS-CoV-2 virus.
    Nat Immunol. 2024 Feb 20. doi: 10.1038/s41590-024-01744.
    >> Share

  5. YING B, Darling TL, Desai P, Liang CY, et al
    Author Correction: Mucosal vaccine-induced cross-reactive CD8(+) T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
    Nat Immunol. 2024 Feb 15. doi: 10.1038/s41590-024-01781.
    >> Share

  6. YING B, Darling TL, Desai P, Liang CY, et al
    Mucosal vaccine-induced cross-reactive CD8(+) T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
    Nat Immunol. 2024 Feb 9. doi: 10.1038/s41590-024-01743.
    >> Share

    January 2024

  7. Building a next-generation, two-component protein subunit vaccine against monkeypox virus.
    Nat Immunol. 2024 Jan 18. doi: 10.1038/s41590-023-01735.
    >> Share


  8. Baseline immune characteristics linked to pneumococcal vaccine responsiveness in older adults.
    Nat Immunol. 2024 Jan 5. doi: 10.1038/s41590-023-01737.
    >> Share

  9. RAVICHANDRAN S, Erra-Diaz F, Karakaslar OE, Marches R, et al
    Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults.
    Nat Immunol. 2024 Jan 5. doi: 10.1038/s41590-023-01717.
    >> Share

  10. RESCIGNO M
    BCG-mediated viral protection goes biphasic.
    Nat Immunol. 2024;25:13-14.
    >> Share

    December 2023
  11. FORD ES, Mayer-Blackwell K, Jing L, Laing KJ, et al
    Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8(+) T cells in persons with previous COVID-19.
    Nat Immunol. 2023 Dec 6. doi: 10.1038/s41590-023-01692.
    >> Share

    November 2023
  12. LEE A, Floyd K, Wu S, Fang Z, et al
    BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance.
    Nat Immunol. 2023 Nov 30. doi: 10.1038/s41590-023-01700.
    >> Share

    October 2023
  13. MILLS KHG
    How immunology can help reverse the pertussis vaccine failure.
    Nat Immunol. 2023 Oct 2. doi: 10.1038/s41590-023-01625.
    >> Share

    September 2023
  14. PAINTER MM, Johnston TS, Lundgreen KA, Santos JJS, et al
    Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection.
    Nat Immunol. 2023 Sep 21. doi: 10.1038/s41590-023-01613.
    >> Share

  15. ZHANG B, Upadhyay R, Hao Y, Samanovic MI, et al
    Multimodal single-cell datasets characterize antigen-specific CD8(+) T cells across SARS-CoV-2 vaccination and infection.
    Nat Immunol. 2023 Sep 21. doi: 10.1038/s41590-023-01608.
    >> Share

  16. ANTOUN E, Peng Y, Dong T
    Vaccine-induced CD8(+) T cells are key to protection from SARS-CoV-2.
    Nat Immunol. 2023 Sep 21. doi: 10.1038/s41590-023-01621.
    >> Share

    August 2023
  17. HASSERT M, Harty JT
    Alt-RNAtive vaccines elicit anti-malarial T(RM) cells.
    Nat Immunol. 2023 Aug 14. doi: 10.1038/s41590-023-01594.
    >> Share

    July 2023
  18. GANLEY M, Holz LE, Minnell JJ, de Menezes MN, et al
    mRNA vaccine against malaria tailored for liver-resident memory T cells.
    Nat Immunol. 2023 Jul 20. doi: 10.1038/s41590-023-01562.
    >> Share

    June 2023
  19. GAO GF
    Two-birds-one-stone approach to combine protein and mRNA vaccines for COVID-19.
    Nat Immunol. 2023 Jun 19. doi: 10.1038/s41590-023-01539.
    >> Share

  20. KAPLONEK P, Cizmeci D, Kwatra G, Izu A, et al
    ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.
    Nat Immunol. 2023 Jun 15. doi: 10.1038/s41590-023-01513.
    >> Share


  21. Immunity to COVID after vaccination in First Nations peoples is affected by comorbidities.
    Nat Immunol. 2023;24:901-902.
    >> Share

  22. ZHANG W, Kedzierski L, Chua BY, Mayo M, et al
    Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities.
    Nat Immunol. 2023;24:966-978.
    >> Share

    May 2023
  23. SILVA-CAYETANO A, Fra-Bido S, Robert PA, Innocentin S, et al
    Spatial dysregulation of T follicular helper cells impairs vaccine responses in aging.
    Nat Immunol. 2023 May 22. doi: 10.1038/s41590-023-01519.
    >> Share

  24. JEYANATHAN M, Vaseghi-Shanjani M, Afkhami S, Grondin JA, et al
    Author Correction: Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis.
    Nat Immunol. 2023 May 9. doi: 10.1038/s41590-023-01525.
    >> Share

    April 2023
  25. VISAN I
    Primary vaccination imprint.
    Nat Immunol. 2023 Apr 24. doi: 10.1038/s41590-023-01515.
    >> Share

  26. NUNEZ NG, Schmid J, Power L, Alberti C, et al
    High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity.
    Nat Immunol. 2023 Apr 24. doi: 10.1038/s41590-023-01499.
    >> Share

    March 2023
  27. VISAN I
    Vaccine-induced memory.
    Nat Immunol. 2023 Mar 23. doi: 10.1038/s41590-023-01489.
    >> Share

    January 2023

  28. Lipid homeostasis mediated by cholesterol synthesis supports B cell responses to vaccination.
    Nat Immunol. 2023 Jan 6. doi: 10.1038/s41590-022-01400.
    >> Share

  29. HOUSTON S
    SARS-CoV-2 mucosal vaccine.
    Nat Immunol. 2023;24:1.
    >> Share

    December 2022
  30. PALIN AC, Alter G, Crotty S, Ellebedy AH, et al
    Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability.
    Nat Immunol. 2022 Dec 26. doi: 10.1038/s41590-022-01414.
    >> Share

  31. JEYANATHAN M, Vaseghi-Shanjani M, Afkhami S, Grondin JA, et al
    Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis.
    Nat Immunol. 2022 Dec 1. doi: 10.1038/s41590-022-01354.
    >> Share

  32. PALIN AC, Alter G, Crotty S, Ellebedy AH, et al
    The persistence of memory: defining, engineering, and measuring vaccine durability.
    Nat Immunol. 2022 Dec 1. doi: 10.1038/s41590-022-01359.
    >> Share

    November 2022
  33. PEDROZA-PACHECO I, McMichael AJ
    Immune signature atlas of vaccines: learning from the good responders.
    Nat Immunol. 2022 Nov 28. doi: 10.1038/s41590-022-01361.
    >> Share

    October 2022
  34. FOURATI S, Tomalin LE, Mule MP, Chawla DG, et al
    Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination.
    Nat Immunol. 2022 Oct 31. pii: 10.1038/s41590-022-01329.
    >> Share

  35. HAGAN T, Gerritsen B, Tomalin LE, Fourati S, et al
    Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses.
    Nat Immunol. 2022 Oct 31. pii: 10.1038/s41590-022-01328.
    >> Share

  36. QUAST I, Tarlinton D
    Time is of the essence for vaccine success.
    Nat Immunol. 2022 Oct 21. pii: 10.1038/s41590-022-01347.
    >> Share

    September 2022
  37. BRASU N, Elia I, Russo V, Montacchiesi G, et al
    Memory CD8(+) T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination.
    Nat Immunol. 2022 Sep 22. pii: 10.1038/s41590-022-01313.
    >> Share

    July 2022
  38. HERATI RS, Knorr DA, Vella LA, Silva LV, et al
    PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01274.
    >> Share

  39. KEDZIERSKA K, Nguyen THO
    PD-1 blockade unblocks immune responses to vaccination.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01254.
    >> Share

  40. YU D, Walker LSK, Liu Z, Linterman MA, et al
    Targeting TFH cells in human diseases and vaccination: rationale and practice.
    Nat Immunol. 2022 Jul 11. pii: 10.1038/s41590-022-01253.
    >> Share

  41. QI H, Liu B, Wang X, Zhang L, et al
    The humoral response and antibodies against SARS-CoV-2 infection.
    Nat Immunol. 2022;23:1008-1020.
    >> Share

    May 2022
  42. LUSTIG Y, Gonen T, Meltzer L, Gilboa M, et al
    Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
    Nat Immunol. 2022 May 9. pii: 10.1038/s41590-022-01212.
    >> Share

    March 2022

  43. IL-1-mediated inflammation induced by different RNA vaccines is context-specific.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01177.
    >> Share

  44. KOBIYAMA K, Ishii KJ
    Making innate sense of mRNA vaccine adjuvanticity.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01168.
    >> Share

  45. TAHTINEN S, Tong AJ, Himmels P, Oh J, et al
    IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
    Nat Immunol. 2022 Mar 24. pii: 10.1038/s41590-022-01160.
    >> Share

  46. LI C, Lee A, Grigoryan L, Arunachalam PS, et al
    Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
    Nat Immunol. 2022 Mar 14. pii: 10.1038/s41590-022-01163.
    >> Share

  47. MARTINEZ DR, Ooi EE
    A potential silver lining of delaying the second dose.
    Nat Immunol. 2022;23:349-351.
    >> Share

    February 2022
  48. TOMALKA JA, Suthar MS, Deeks SG, Sekaly RP, et al
    Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
    Nat Immunol. 2022 Feb 24. pii: 10.1038/s41590-022-01130.
    >> Share

  49. HALL VG, Ferreira VH, Wood H, Ierullo M, et al
    Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses.
    Nat Immunol. 2022 Feb 3. pii: 10.1038/s41590-021-01126.
    >> Share

    January 2022
  50. EGWANG TG, Owalla TJ, Kemigisha M
    COVID-19 vaccine trials must include helminth-infected cohorts.
    Nat Immunol. 2022 Jan 24. pii: 10.1038/s41590-021-01116.
    >> Share

  51. DOWELL AC, Butler MS, Jinks E, Tut G, et al
    Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
    Nat Immunol. 2022;23:40-49.
    >> Share

    December 2021
  52. BERNARD NJ
    Vaccine thrombosis.
    Nat Immunol. 2021 Dec 22. pii: 10.1038/s41590-021-01111.
    >> Share

    November 2021
  53. BREWER RC, Ramadoss NS, Lahey LJ, Jahanbani S, et al
    BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
    Nat Immunol. 2021 Nov 30. pii: 10.1038/s41590-021-01088.
    >> Share

  54. IRVINE EB, O'Neil A, Darrah PA, Shin S, et al
    Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Nat Immunol. 2021 Nov 22. pii: 10.1038/s41590-021-01066.
    >> Share


  55. NIAID workshop on secondary vaccine effects.
    Nat Immunol. 2021;22:1363-1366.
    >> Share

    October 2021
  56. CORBETT KS, Werner AP, Connell SO, Gagne M, et al
    mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
    Nat Immunol. 2021;22:1306-1315.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016